Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca2+](i) and force in middle cerebral artery of the rabbit

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 869-878

  Shiraishi, Yoshihisa ^a,b   Kanmura, Yuichi ^c   Itoh, Takeo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Agonist induced Ca2+ release; Cerebral vessels; Cilostazol; Histamine induced Ca2+ mobilization; Myofilament Ca2+ sensitivity; Phosphodiesterase

Indexed keywords

CAFFEINE; CALCIUM ION; CILOSTAZOL; CYCLIC AMP; EGTAZIC ACID; HISTAMINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOROTHIOIC ACID; POTASSIUM ION; RYANODINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR SMOOTH MUSCLE;

EID: 0031951374     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701699     Document Type: Article

References (29)

1. BARON, J.C., DELATTRE, J.Y., BORIES, J., CHIRAS, J., CABANIS, E.A., BLAS, C., BOUSSER, M.G. & COMAR, D. (1983). Comparison study of CT and positron emission tomographic data in recent cerebral infarction. Am. J. Neuroradiol., 4, 536-540.
2. BEAVO, J.A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 75, 725-748.
3. CALDICOTT, L.D., HAWLEY, K., HEPPELL, R., WOODMANSEY, P.A. & CHANNER, K.S. (1993). Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. Eur. Heart J., 14, 696-700.
4. CAPON, A., DE ROOD, M., VERBIST, A. & FRUHLING, J. (1977). Action of vasodilators on regional cerebral blood flow in subacute or chronic cerebral ischemia. Stroke, 8, 25-29.
5. DOSTMANN, W.R. (1995). (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition. FEBS Lett., 375, 231-234.
6. FIELDS, W.S., LEMAK, N.A., FRANKOWSKI, R.F. & HARDY, R.J. (1977). Controlled trial of aspirin in cerebral ischemia. Stroke, 8, 301-314.
7. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
8. 2+ mobilization in smooth muscle of rabbit mesenteric artery. Br. J. Pharmacol., 110, 1117-1125.
9. 2+ mobilization in smooth muscle of the rabbit mesenteric artery. Br. J. Pharmacol., 111, 165-172.
10. 2+ mobilization and tension in arterial smooth muscle of the rabbit. J. Physiol., 457, 297-314.
11. ITOH, T., SEKI, N., SUZUKI, S., ITO, S., KAJIKURI, J. & KURIYAMA, H. (1992b). Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J. Physiol., 451, 307-328.
12. KAWAMURA, K., FUJITA, S., TANI, T. & KIMURA, Y. (1985). Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency. Arzneim.-Forseh./ Drug Res., 35, 1154-1156.
13. KIMURA, Y., TANI, T., KANBE, T. & WATANABE, K. (1985). Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneim.-Forsch./Drug Res., 35, 1144-1149.
14. KOMAS, N., LUGNIER, C. & STOCLET, J.C. (1991). Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitor. Br. J. Pharmacol., 104, 495-503.
15. KURIYAMA, H., KITAMURA, K. & NABATA, H. (1995). Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev., 47, 387-573.
16. LINDGREN, S. & ANDERSSON, K.E. (1991). Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat. Acta Physiol. Scand., 142, 77-82.
17. MANGANIELLO, V.C., TAIRA, M., DEGERMAN, E. & BELFRAGE, P. (1995). Type III cGMP-inhibited cycle nucleotide phosphodiesterases (PDE 3 gene family). Cell. Signal, 7, 445-455.
18. OHYA, Y., KITAMURA, K. & KURIYAMA, H. (1987). Modulation of ionic currents in smooth muscle halls of the rabbit intestine by intracellularly perfused ATP and cyclic AMP. Pflügers Arch., 408, 465-473.
19. POENIE, M., ALDERTON, J., STEINHARDT, R. & TSIEN, R. (1986). Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. Science, 233, 886-889.
20. POLSON, J.B. & STRADA, S.J. (1996). Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol., 36, 403-427.
21. 2+ entry revisited. Cell Calcium., 11, 611-624.
22. SHAFIQ, J., SUZUKI, S., ITOH, T. & KURIYAMA, H. (1992). Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. Circ. Res., 71, 70-81.
23. SHINTANI, S., WATANABE, K., KAWAMURA, T., MIRI, T., TANI, Y., TOBA, H., SASABE, N., NAKAGIRI, N., HONGOH, O., FUJITA, S., AOGI, T., KIDO, Y., UMEZATO, M., ISHIKAWA, M. & HIYAMA, T. (1985). General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs. Arzneim.-Forsch./Drug Res., 35, 1163-1172.
24. SILVER, P.J., LEPORE, R.E., O'CONNOR, B., LEMP, B.M., HAMEL, L.T., BENTLEY, R.G. & HARRIS, A.L. (1988). Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. J. Pharmacol. Exp. Ther., 247, 34-42.
25. TANAKA, T., ISHIKAWA, T., HAGIWARA, M., ONODA, K., ITOH, H. & HIDAKA, H. (1988). Effect of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology, 36, 313-320.
26. UCHIYAMA, S., TAKEUCHI, M., OSAWA, M., KOBAYASHI, I., MARUYAMA, S., AOSAKI, M. & HIROSAWA, K. (1983). Platelet function tests in thrombotic cerebrovascular disorders. Stroke, 14, 511-517.
27. UMEKAWA, H., TANAKA, H., KIMURA, Y. & HIDAKA, H. (1984). Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography. Biochem. Pharmacol., 33, 3339-3344.
28. 2+ mobilization in rabbit arterial smooth muscle. Br. J. Pharmacol., 117, 1302-1308.
29. WEISHAAR, R.E., BURROWS, S.D., KOYLARZ, D.C., QUADE, M.M. & EVANS, D.B. (1986). Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem. Pharmacol., 35, 787-800.